focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.025
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.05 (5.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.025
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

5 Feb 2021 08:01

RNS Number : 0851O
Microsaic Systems plc
05 February 2021
 

 

5 February 2021

 

Microsaic Systems plc

("Microsaic" or the "Company")

Board changes

Microsaic (AIM: MSYS), the point-of-need mass spectrometry company, is pleased to announce that, further to the fundraise announcements on 19 January 2021 and the passing of the resolutions at the General Meeting held yesterday, Gerard Brandon and Dr Nigel Burton are appointed to the Board of the Company as Non-Executive Chairman and Non-executive Director respectively, with effect from 8.00 a.m. today.

The Finance & Audit and Remuneration Committees will be chaired by Dr. Nigel Burton, and Gerard Brandon will be a member of both committees. Dr. Nigel Burton will assume the responsibilities of Senior Non-Executive Director. These arrangements will be reviewed when an independent Non-executive Director joins the Board.

 

Gerard Brandon is Chief Executive Officer of both DeepVerge plc and Cellulac plc. In 1996 he became founder and CEO of Alltracel Pharmaceuticals plc ("Alltracel"), where he built a team which oversaw numerous patents granted on refined cellulose. Alltracel was admitted to trading on AIM in 2001. In 2004, he was appointed as a Managing Partner for Farmabrand Private Equity. In March 2020, he was appointed as a Non-executive Chairman to Modern Water plc, which was subsequently acquired by DeepVerge plc (formerly Integumen plc) in November 2020. Gerard is a Fellow of the Ryan Academy of Entrepreneurs in Dublin.

Dr. Nigel Burton spent over 14 years as an investment banker at leading City institutions including UBS Warburg and Deutsche Bank, including as the Managing Director responsible for the energy and utilities industries. Nigel spent 15 years as Chief Financial Officer or Chief Executive Officer of a number of private and public companies. Nigel is currently a Non-executive Director of LSE Main Market listed BlackRock Throgmorton Trust plc, and of the AIM quoted companies Digitalbox plc, eEnergy Group plc and Mobile Streams plc. In February 2020, he was appointed as a Non-executive Director of Modern Water plc, which was subsequently acquired by DeepVerge plc (formerly Integumen plc) in November 2020, following which he became a Non-executive Director of DeepVerge plc.

As anticipated in the Circular published on 19 January 2021, Peter Grant, Non-executive Chairman and Eric Yeatman, Non-executive Director, stepped down from the Board with effect from 8.00 a.m. today. Eric Yeatman will be retained as a consultant.

Gerard Brandon, Chairman, said:

"Nigel and I are delighted to be joining the Board and look forward to working with, and supporting, management to commercialise the amazing technology built over the last 19 years. Investing in the recent Placing and taking our respective Director fees only in shares, we have full confidence for the future of Microsaic.

The Company would also like to take this opportunity to thank Peter Grant for his contribution as Chairman over the past three years and Professor Eric Yeatman for his contribution as one of the original founders of the Company and a Director since 2001. We are pleased to be retaining Eric as a consultant to the Company given his expert knowledge of the Company's technology and business."

 

Enquiries:

Microsaic Systems plc

 

 

 

Glenn Tracey, CEO

+44 (0) 1483 751 577

Bevan Metcalf, FD

 

 

N+1 Singer

 

+44 (0) 20 7496 3000

(Nominated Adviser and Joint Broker)Aubrey Powell / George Tzimas / Tom Salvesen

 

 

Turner Pope Investments (TPI) Limited (Joint Broker)

+44 (0) 20 3657 0050

Zoe Alexander / Andy Thacker

 

 

 

In accordance with obligations under the AIM Rules Schedule 2(g), Gerard James Brandon, 59, holds or has held the following directorships in the previous five years:

Current directorships

Past directorships

Innovenn UK Ltd

Visible Youth Limited

Deepverge plc (nee Integumen plc)

VY Club Ltd

Pursuit Marine Drive Ltd

Cellulac plc

Cellulac Trading Ltd

Rincloud Ltd

Modern Water plc

Parity Group plc

Integumen Ltd

LifescienceHub UK Limited

AER Sustainable Energy Limited

LifescienceHub Ireland Limited

Integumen Ireland Limited

Stoer Ireland Limited

 

In accordance with obligations under the AIM Rules Schedule 2(g), Dr. Nigel John Burton, 62, holds or has held the following directorships in the previous five years:

Current directorships

Past directorships

Wasdale Head Limited

Management Resource Solutions plc

Wasdale Head Inn Limited

Nu-Oil and Gas plc

SenseToys Limited

Remote Monitored Systems plc

ASD Visual Aids Limited

GyroMetric Systems Limited

Digitalbox plc

Strat Aero International Limited

Tau Capital plc

UKAerovision Limited

Energy Group plc

Corcel plc

Mobile Streams plc

Streams Data Limited

Mobile Streams Inc

Modern Water plc

eEnergy Holdings Limited

DeepVerge plc

Blackrock Throgmorton Trust plc

 

 

Dr Burton was a director of Pease Limited within the 12 months prior to the company appointing a liquidator in June 1998. The company was subsequently liquidated in 2002.

 

There is no further information to be disclosed pursuant to Schedule 2(g) of the AIM Rules for Companies.

Dr. Burton currently holds 500,000 ordinary shares in Microsaic Systems plc. A separate announcement is today being made confirming the interests of Mr. Brandon and Dr. Burton following completion of the fundraising for the Company.

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company which develops point-of-need mass spectrometers (MS) designed to improve the efficiency of chemical and biological workflows.

The Company was initially established to develop miniaturised MS instruments based on micro-electromechanical systems (MEMS) technology originating at the highly regarded Optical and Semiconductor Devices Group at Imperial College London. Since being established in 2001, the Company has invested substantially in core intellectual property specific to its miniaturised MS, with over 60 patents in chip based, compact MS.

The Company has sold over 160 instruments to date and has signed over ten commercial partners, including in North America, Europe, China, SE Asia and Japan, with the majority of signings occurring in 2018 and 2019. For more information, please go to www.microsaic.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATIMTTMTBMTFB
Date   Source Headline
15th Mar 20227:00 amRNSBoard Appointment and Strategic Update
8th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20222:05 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20221:31 pmRNSHolding(s) in Company
17th Feb 20222:45 pmRNSHolding(s) in Company
16th Feb 202211:06 amRNSSecond Price Monitoring Extn
16th Feb 202211:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSDirector Dealing, Issue of Equity and TVR
28th Jan 20227:00 amRNSResignation of Chief Executive Officer
12th Jan 20224:43 pmRNSHolding(s) in Company
10th Jan 20223:30 pmRNSInvestor Presentation
10th Jan 20227:00 amRNSTrading Update
7th Jan 20222:06 pmRNSSecond Price Monitoring Extn
7th Jan 20222:00 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSFurther order from DeepVerge
12th Nov 20217:00 amRNSNew compact screening platform
5th Nov 202110:12 amRNSHolding(s) in Company
27th Oct 20217:00 amRNSLaunch of technology for scaling drug manufacture
22nd Oct 20217:00 amRNSBoard Change
21st Oct 20217:00 amRNSUpdate on DeepVerge Collaboration
28th Sep 20214:30 pmRNSHolding(s) in Company
27th Sep 20217:00 amRNSInterim Results
24th Sep 20217:00 amRNSSigning of agreement to support China operations
22nd Sep 202111:06 amRNSNotice of Results and Investor Presentation
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Aug 20217:00 amRNSDeepVerge Collaboration for Water & Soil Analysis
9th Aug 20217:00 amRNSHeads of Terms signed with manufacturer in China
6th Jul 202111:55 amRNSInvestor Presentation
6th Jul 20217:00 amRNSTrading update for H1 2021
5th Jul 20219:50 amRNSHolding(s) in Company
2nd Jul 20217:00 amRNSDevelopment of real-time monitoring solution
17th Jun 202110:54 amRNSResult of Annual General Meeting
4th Jun 20217:00 amRNSPre-Annual General Meeting Q&A
25th May 20217:00 amRNSDevelopment of PFAS detection platform
20th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:01 amRNSHeads of Terms signed for Chinese market
4th May 20217:00 amRNSFinal Results
28th Apr 20217:00 amRNSNotice of Results and Investor Presentation
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSFramework Services Agreement Update
9th Mar 20212:52 pmRNSHolding(s) in Company
9th Mar 20212:06 pmRNSSecond Price Monitoring Extn
9th Mar 20212:01 pmRNSPrice Monitoring Extension
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.